Galectin Therapeutics Inc. (GALT): Here's the information on todays mar...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	3183
Posts	208744
Boards Moderated	2
Alias Born	02/04/2004

doogdilinger

Re: None

Tuesday, 09/29/2020 10:37:45 AM

Tuesday, September 29, 2020 10:37:45 AM

Here's the information on todays market close Conference Call folks>>>

Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020

September 22 2020 - 08:04AM
GlobeNewswire Inc.

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that the Company will host an investor conference call and webinar to discuss the Company’s NASH-RX clinical trial and to introduce its new CEO, Joel Lewis. The Investor Call is scheduled for Tuesday, September 29, 2020, at 4:00 p.m. EDT.

The presentation can be accessed by dialing (844) 899-6544 and entering the conference ID: 3695038 or at the following webcast link: https://edge.media-server.com/mmc/p/hmudntyg. A copy of the presentation to be used for the call can be found on the Company’s website at https://investor.galectintherapeutics.com/investor-relations.

The call is expected to last one hour, including a Q&A session that will follow the formal remarks. The Company encourages the investment community to submit their questions in advance to: info@galectintherapeutics.com and no later than Friday, September 25th at 4 PM EDT.